Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma. — John Koutsikos (2005) | RDL Network
Combined use of 99mTc-sestamibi and 99mTc-V-DMSA in the assessment of chemotherapy effectiveness in patients with multiple myeloma.
Article 2005 en
Authors
JK
John Koutsikos
TA
Theodoros Athanasoulis
ΑA
Αchilles Anagnostopoulos
Abstract
1 min read
Combined use of the 2 agents allows the effectiveness of chemotherapy to be evaluated through a comparison of NAL and TPL multiple myeloma lesions even in the absence of a baseline study.
Kristine A. Frerichs, Christie P.M. Verkleij, Meletios A Dimopoulos, Jhon A. Marin Soto, Sonja Zweegman, Mary H. Young, Kathryn J. Newhall, Tuna Mutis, Niels W.C.J. van de Donk
Discussion(0)
No comments yet. Be the first to comment.